133 related articles for article (PubMed ID: 38180732)
1. Probable effects of polypharmacy and equivalent doses of psychotropic drugs on prevalence of adverse drug events among psychiatric inpatients in a general hospital in Japan.
Aoyama K; Tachi T; Kubo S; Koyama A; Watanabe M; Aoyama S; Noguchi Y; Tanaka K; Yasuda M; Shibata A; Mizui T; Teramachi H
Hum Psychopharmacol; 2024 May; 39(3):e2890. PubMed ID: 38180732
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429
[TBL] [Abstract][Full Text] [Related]
3. Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults With Alzheimer Disease, 2013-2014.
Sepassi A; Watanabe JH
Ann Pharmacother; 2019 Dec; 53(12):1173-1183. PubMed ID: 31342766
[No Abstract] [Full Text] [Related]
4. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of adverse drug events and medication errors among psychiatric inpatients in Japan: the JADE study.
Ayani N; Sakuma M; Morimoto T; Kikuchi T; Watanabe K; Narumoto J; Fukui K
BMC Psychiatry; 2016 Aug; 16(1):303. PubMed ID: 27577925
[TBL] [Abstract][Full Text] [Related]
6. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
8. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury.
Hand BN; Krause JS; Simpson KN
Spinal Cord; 2018 Jun; 56(6):591-597. PubMed ID: 29362505
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events in an intensive care unit of a university hospital.
Reis AM; Cassiani SH
Eur J Clin Pharmacol; 2011 Jun; 67(6):625-32. PubMed ID: 21246350
[TBL] [Abstract][Full Text] [Related]
11. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
[TBL] [Abstract][Full Text] [Related]
12. [Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention].
Hahn M; Braus DF
Versicherungsmedizin; 2012 Sep; 64(3):127-31. PubMed ID: 22997674
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.
Laatikainen O; Miettunen J; Sneck S; Lehtiniemi H; Tenhunen O; Turpeinen M
Eur J Clin Pharmacol; 2017 Dec; 73(12):1539-1549. PubMed ID: 28871436
[TBL] [Abstract][Full Text] [Related]
14. Hospital admissions caused by adverse drug events: an Australian prospective study.
Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
[TBL] [Abstract][Full Text] [Related]
15. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
Hirano Y; Ii Y
Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients.
Anand TV; Wallace BK; Chase HS
BMC Geriatr; 2021 Nov; 21(1):648. PubMed ID: 34798832
[TBL] [Abstract][Full Text] [Related]
17. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
Kuklik N; Stausberg J; Amiri M; Jöckel KH
BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
[TBL] [Abstract][Full Text] [Related]
18. Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China.
Wu S; Yin Q; Wu L; Wu Y; Yu N; Yan J; Bian Y
BMC Health Serv Res; 2024 Jan; 24(1):72. PubMed ID: 38225629
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug event-related hospitalisation in persons with neurodevelopmental disorders: a state-wide retrospective cohort study.
Zhou M; Du W; Salvador-Carulla L; Glasgow N
J Intellect Disabil Res; 2019 May; 63(5):429-440. PubMed ID: 30609156
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug events identified by triggers at a teaching hospital in Brazil.
Giordani F; Rozenfeld S; Martins M
BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
